About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Pancreatic Cancer Stem Cells Targeted and Killed by Oncolytic Viruses

by Kathy Jones on May 10, 2011 at 6:53 PM
Font : A-A+

 Pancreatic Cancer Stem Cells Targeted and Killed by Oncolytic Viruses

New research from Memorial Sloan-Kettering Cancer Center in New York says that oncolytic viruses quickly infect and kill cancer stem cells, which may provide a treatment for tumors that are resistant to conventional chemotherapy and radiation, particularly pancreatic cancer.

The findings are especially important since pancreatic cancer has a poor prognosis and is difficult to detect and treat at early stages.

Advertisement

Investigators led by Joyce Wong, MD, surgical researcher with Memorial Sloan-Kettering Cancer Center, investigated whether they could use oncolytic viruses, which are naturally occurring viruses that have been genetically engineered to be safe and express tracking genes, as a possible therapy against pancreatic cancer stem cells. These stem cells are thought to cause disease recurrence and metastasis, even after therapy, and oncolytic viruses may offer a new treatment strategy.

"What we learned is that oncolytic viruses have been engineered to selectively target cancer cells and have a low toxicity profile in animal studies," said Dr. Wong. "Targeting the cancer stem cell may enhance our ability to eradicate tumors and prevent future recurrence of disease."
Advertisement

While much research has been performed on isolating the cancer stem cell from various hematologic cancers, this research was based on the presence or absence of certain cell surface markers. Numerous mechanisms of how these cancer stem cells resist chemotherapy and radiation have also been examined. But to date, there have not been any studies evaluating whether genetically engineered viruses can target and kill pancreatic cancer stem cells.

Investigators sought to determine whether the viruses containing a marker gene that expresses green fluorescent protein could infect pancreatic cancer stem cells and ultimately kill the cancer stem cell. Their findings were promising and documented that viral activity was correlated with green fluorescent protein expression.

Dr. Wong added that future studies are warranted to determine whether oncolytic virus administration in vivo will help eradicate tumors and prevent future disease recurrence, and that while these initial findings are encouraging, further study is necessary to see whether oncolytic viruses will be clinically useful as a therapy.

Dr. Wong will present these data on Monday, May 9 at 10:00 a.m. CT in S505, McCormick Place.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 9 Reasons Why We Should Practice Kindness
Top 10 Vitamin B12 Foods for Vegetarians - Slideshow
Targeted Screening Program Beneficial for Prostate Cancer Screening
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pancreatic Cancer Stem Cells - Cord Blood Stem Cells - Fundamentals Cancer and Homeopathy Parkinsons Disease Surgical Treatment Genetics and Stem Cells Cancer Facts Cancer Tattoos A Body Art Pancreatitis 

Most Popular on Medindia

How to Reduce School Bag Weight - Simple Tips Hearing Loss Calculator Blood - Sugar Chart A-Z Drug Brands in India Daily Calorie Requirements Sanatogen Blood Pressure Calculator Iron Intake Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Vent Forte (Theophylline)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use